JPMorgan Upgrades H.B. Fuller to Neutral From Underweight, $58 Price Target
May 27, 2026
JPMorgan upgraded H.B. Fuller to Neutral with a $58 price target amid activist pressure to review its acquisition of Advanced Medical Solutions. The company manufactures adhesives, sealants, and specialty chemical products.
2026-04-06
A Look At H.B. Fuller (FUL) Valuation After Higher Earnings And Raised 2026 Revenue Guidance2026-04-19
Does H.B. Fuller’s (FUL) Higher Dividend Payout Reveal Its True Capital Allocation Priorities?2026-04-21
The Mosaic Company Is the Most Oversold Materials Stock as Q1 Earnings Roll On (XLB:NYSEARCA)2026-04-24
HB Fuller Q1 2026 Earnings PreviewShow all 37 updates